Skip to main content

Table 3 A list of investigational drugs currently in clinical development as potential treatments for epilepsy. The list is not exhaustive and does not include medications approved for other indications and currently being tested for potential repurposing in epilepsy

From: The pharmacological treatment of epilepsy: recent advances and future perspectives

Anavex 2–73

Omaveloxolone (RTA 408)

Ataluren

OV 329

Carisbamate

Sec-butylpropylacetamide

CVL 865 (PF-03672865)

Soticlestat (TAK 935, OV935)

CX8998

Vatiquinone (EPI-743)

Ganaxolone

Vixotrigine (CNV 1014802)

Huperzyne A

XEN 496

JJ 40411813

XEN 1101

NBI 921352 (XEN 901)

Â